120 related articles for article (PubMed ID: 3712039)
1. No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice.
Shiue CY; Fowler JS; Wolf AP; McPherson DW; Arnett CD; Zecca L
J Nucl Med; 1986 Feb; 27(2):226-34. PubMed ID: 3712039
[TBL] [Abstract][Full Text] [Related]
2. (3-N-[11C]methyl)spiperone, a ligand binding to dopamine receptors: radiochemical synthesis and biodistribution studies in mice.
Burns HD; Dannals RF; Langström B; Ravert HT; Zemyan SE; Duelfer T; Wong DF; Frost JJ; Kuhar MJ; Wagner HN
J Nucl Med; 1984 Nov; 25(11):1222-7. PubMed ID: 6333496
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levels.
MacGregor RR; Schlyer DJ; Fowler JS; Wolf AP; Shiue CY
J Nucl Med; 1987 Jan; 28(1):60-7. PubMed ID: 3491887
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.
Shiue CY; Fowler JS; Wolf AP; Watanabe M; Arnett CD
J Nucl Med; 1985 Feb; 26(2):181-6. PubMed ID: 2857191
[TBL] [Abstract][Full Text] [Related]
5. [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.
Arnett CD; Fowler JS; Wolf AP; Shiue CY; McPherson DW
Life Sci; 1985 Apr; 36(14):1359-66. PubMed ID: 3872397
[TBL] [Abstract][Full Text] [Related]
6. Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol.
Kilbourn MR; Welch MJ; Dence CS; Tewson TJ; Saji H; Maeda M
Int J Appl Radiat Isot; 1984 Jul; 35(7):591-8. PubMed ID: 6469389
[TBL] [Abstract][Full Text] [Related]
7. A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET.
Fowler JS; Arnett CD; Wolf AP; Shiue CY; MacGregor RR; Halldin C; Långström B; Wagner HN
Int J Rad Appl Instrum B; 1986; 13(3):281-4. PubMed ID: 3771261
[TBL] [Abstract][Full Text] [Related]
8. No-carrier-added N-(3-[18F]fluoropropyl)spiroperidol: biodistribution in mice and tomographic studies in a baboon.
Shiue CY; Bai LQ; Teng RR; Arnett CD; Wolf AP
J Nucl Med; 1987 Jul; 28(7):1164-70. PubMed ID: 3496434
[TBL] [Abstract][Full Text] [Related]
9. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR
J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of N-methyl and N-11C-methyl spiperone by phase transfer catalysis in anhydrous solvent.
Omokawa H; Tanaka A; Iio M; Nishihara Y; Inoue O; Yamazaki T
Radioisotopes; 1985 Sep; 34(9):480-5. PubMed ID: 4089233
[TBL] [Abstract][Full Text] [Related]
11. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography.
Satyamurthy N; Bida GT; Barrio JR; Luxen A; Mazziotta JC; Huang SC; Phelps ME
Int J Rad Appl Instrum B; 1986; 13(6):617-24. PubMed ID: 3494003
[TBL] [Abstract][Full Text] [Related]
12. Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor.
Welch MJ; Kilbourn MR; Mathias CJ; Mintun MA; Raichle ME
Life Sci; 1983 Oct; 33(17):1687-93. PubMed ID: 6633162
[TBL] [Abstract][Full Text] [Related]
13. [11C]spiroperidol: synthesis, specific activity determination, and biodistribution in mice.
Fowler JS; Arnett CD; Wolf AP; MacGregor RR; Norton EF; Findley AM
J Nucl Med; 1982 May; 23(5):437-45. PubMed ID: 6281403
[No Abstract] [Full Text] [Related]
14. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors.
Mazière B; Loc'h C; Hantraye P; Guillon R; Duquesnoy N; Soussaline F; Naquet R; Comar D; Mazière M
Life Sci; 1984 Sep; 35(13):1349-56. PubMed ID: 6332966
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET).
Dewey SL; Logan J; Wolf AP; Brodie JD; Angrist B; Fowler JS; Volkow ND
Synapse; 1991 Apr; 7(4):324-7. PubMed ID: 2042113
[No Abstract] [Full Text] [Related]
16. The synthesis of no-carrier-added DL-4-[18F]fluorodeprenyl via the nucleophilic aromatic substitution reaction.
Plenevaux A; Fowler JS; Dewey SL; Wolf AP; Guillaume M
Int J Rad Appl Instrum A; 1991; 42(2):121-7. PubMed ID: 1648033
[TBL] [Abstract][Full Text] [Related]
17. 3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans.
Satyamurthy N; Barrio JR; Bida GT; Huang SC; Mazziotta JC; Phelps ME
Int J Rad Appl Instrum A; 1990; 41(2):113-29. PubMed ID: 2158942
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vivo evaluation of [18F]-N-(p-nitrobenzyl)spiperone ([18F]PNBS) in rats.
Mach RH; Nowak PA; Moroney DA; Morton TE; Jackson JR; Ehrenkaufer RL
Nucl Med Biol; 1993 Apr; 20(3):269-78. PubMed ID: 8485486
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, distribution, binding characteristics in mice and rats and a PET study in monkey.
Shiue CY; Shiue GG; Rysavy JA; Pleus RC; Huang H; Bai LQ; Cornish KG; Sunderland JJ; Frick MP
Nucl Med Biol; 1993 Nov; 20(8):973-81. PubMed ID: 8298577
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens.
Kiesewetter DO; Eckelman WC; Cohen RM; Finn RD; Larson SM
Int J Rad Appl Instrum A; 1986; 37(12):1181-8. PubMed ID: 3028984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
